Project Updates

Credit; Commonwealth of Pennsylvania. 

Location: Philadelphia, USA 
Project type: Gene Therapy Innovation Center 
Expected Completion: 2026 
Estimated Investment: Phase 1: $575m

Spark Therapeutics, a US-based biotechnology company and a member of the Roche Group, began construction of a new Gene Therapy Innovation Center on Drexel University’s campus. The facility will serve as Roche’s global centre of excellence for gene therapy manufacturing.

Credit; Boehringer Ingelheim

Location: Biberach, Germany 
Project type: Research and development facility 
Construction Started: June 2018 
Completed: April 2023

Boehringer Ingelheim developed a biologicals development centre and invested €350m ($384.6m) in the state-of-the-art facility. It is Europe’s largest development centre in biotechnology. The facility is used for conducting advanced research for cancer, stroke and heart disease and other conditions.

Credit; Cellares Corporation

Location: Bridgewater, New Jersey, US 
Project type: Cell therapy development facility 
Estimated Investment: $255m 
Expected Completion: 2024

Cellares, a US-based Integrated Development and Manufacturing Organization (IDMO) focused on cell therapy, will launch its first IDMO Smart Factory in Bridgewater, New Jersey, US, for pre-clinical, clinical and commercial-scale cell therapy manufacturing.